Edesa Biotech RPE
Quel est le RPE de Edesa Biotech?
Le RPE de Edesa Biotech, Inc. est $0.00
Quelle est la définition de RPE?
Le revenu par employé (RPE) est le revenu divisé par le nombre d'employés d'une organisation.
RPE des entreprises dans Health Care secteur sur NASDAQ par rapport à Edesa Biotech
Que fait Edesa Biotech?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Entreprises avec rpe similaire à Edesa Biotech
- Imperial Pacific International a RPE de -HKD$428.57
- Indosolar a RPE de -₨115.24
- Bluejay Mining Plc a RPE de -£95.27
- Small Pharma Inc a RPE de -CAD$89.38
- Treasury Metals a RPE de -$82.14
- Treasury Metals a RPE de -CAD$4.56
- Edesa Biotech a RPE de $0.00
- medical columbus AG a RPE de €0.45
- Nyrstar NV a RPE de €2.96
- Talon Metals a RPE de CAD$10.55
- Highfield Resources a RPE de AUD$12.94
- Venus Metals a RPE de AUD$15.15
- Buderim a RPE de AUD$54.64